Loading provider…
Loading provider…
Internal Medicine Physician in Orlando, FL
NPI: 1225019284Primary Practice Location
ORLANDO HEALTH
92 W Miller St, Orlando, FL
Primary Employer
Orlando Health Medical Group Inc
orlandohealth.com
HQ Phone
Get MD Kwabena's Phone Numberphone_androidMobile
Get MD Kwabena's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2003 - 2027
VA State Medical License
2001 - 2014
DC State Medical License
2001 - 2013
MD State Medical License
2000 - 2004

American Board of Internal Medicine
Internal Medicine
Providence Hospital
Residency • Internal Medicine
1998 - 2000
Saint Elizabeths Hospital-DC Department of Behavioral Health
Residency • Psychiatry
1996 - 1998
Karlovy University FOM
Medical School
Until 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 135 | 446 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 105 | 304 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 94 | 94 |
| 4 | 99239Hospital discharge day management, more than 30 minutes | 71 | 71 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 40 | 40 |
Authors: Bordon, Jose, Master, Ronald N, Clark, Richard B, Duvvuri, Padmaraj, Karlowsky, James A, Ayesu, Kwabena, Klotchko, Alena, Kapoor, Rama, Ramirez, Julio
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia.
Authors: Juan Guardiola, Raul Nakamatsu, Alena Klochko
Journal: Int J Tuberc Lung Dis
Lead Sponsor: Seres Therapeutics, Inc.
Collaborators: Syneos Health
Intervention / Treatment: DRUG: Placebo, DRUG: SER-109
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
Lead Sponsor: CSL Behring
Intervention / Treatment: DRUG: Placebo, DRUG: human immunoglobulin G